129 related articles for article (PubMed ID: 6503978)
21. [Hemodynamic effects of a large dose injection of OK-432 (picibanil)].
Morita K; Murata T; Marumoto M; Tsuboi H; Nakahara Y; Oda T; Mohri H
Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):295-300. PubMed ID: 6674797
[TBL] [Abstract][Full Text] [Related]
22. [Prevention of peritoneal recurrence by combined intra-peritoneal and intra-tumoral injections of OK-432].
Baba H; Tsujitani S; Korenaga D; Kakeji Y; Haraguchi M; Konoe S; Maehara Y; Sugimachi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1596-9. PubMed ID: 2389954
[TBL] [Abstract][Full Text] [Related]
23. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
24. [Effect of intratumoral injection of the mixture of OK-432 and fibrinogen (OK/fbg) on gastric cancer].
Takeda T; Wakasugi T; Katsumoto Y; Sakita I; Nagaoka H; Morimoto H; Tsujinaka T; Monden T; Shiozaki H; Shimano T
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1458-60. PubMed ID: 1530293
[TBL] [Abstract][Full Text] [Related]
25. [Effect of intra-thoracic administration of an immune modulator (OK-432) with anti-cancer drugs (ADR and MMC)].
Hattori H; Mikuriya S; Mamiya T; Hatano K; Shiina T; Yamada T
Gan No Rinsho; 1988 Jun; 34(7):851-6. PubMed ID: 3135423
[TBL] [Abstract][Full Text] [Related]
26. [Clinical study on the effect of intratumoral administration of OK-432 on breast cancer--anti-tumor immune response at the site of local injection].
Hosokawa T
Nihon Geka Gakkai Zasshi; 1991 May; 92(5):577-86. PubMed ID: 1831533
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
[No Abstract] [Full Text] [Related]
28. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
Fujieda S; Saito H; Isobe Y; Nakagawara G; Nishi O; Nagahara K; Watanabe Y; Hoshino T
Anticancer Res; 1992; 12(6B):1941-5. PubMed ID: 1341892
[TBL] [Abstract][Full Text] [Related]
29. [Local immunotherapy of breast cancer: a case of advanced breast cancer improved by combined local injection therapy with OK-432 and rIL-2].
Fujimori M; Sugenoya A; Kobayashi S; Masuda H; Komatsu M; Takahashi S; Shimizu T; Tsuchiya S; Iida F
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2760-3. PubMed ID: 2551219
[TBL] [Abstract][Full Text] [Related]
30. [Study on enhancement of antitumor immunity in cervical cancer--with reference to administration of immunopotentiators].
Wakida K
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):432-8. PubMed ID: 3559328
[TBL] [Abstract][Full Text] [Related]
31. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
32. [Endoscopic preoperative intralesional injection of OK-432 in early gastric cancer].
Yamane T; Sagara Y; Suzuki G; Kasuga M; Sakita M; Fujita Y; Majima S
Gan To Kagaku Ryoho; 1984 Apr; 11(4):930-4. PubMed ID: 6721507
[TBL] [Abstract][Full Text] [Related]
33. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
Komatsu K; Nakamura W
C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364
[TBL] [Abstract][Full Text] [Related]
34. Intraperitoneal administration of the biological response modifier OK-432 and peritoneal recurrence following gastrectomy.
Tsujitani S; Abe Y; Korenaga D; Saitoh A; Watanabe A; Sugimachi K
Hepatogastroenterology; 1990 Oct; 37(5):498-502. PubMed ID: 2253926
[TBL] [Abstract][Full Text] [Related]
35. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H; Miura S; Asagoe T; Hanaue H; Shikata J
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2305-13. PubMed ID: 2934024
[TBL] [Abstract][Full Text] [Related]
36. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
[TBL] [Abstract][Full Text] [Related]
37. [Immunological study on localized liver injection of immunopotentiator OK-432-- experimental studies in rats].
Takada T; Yasuda H; Uchiyama K; Hasegawa H
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2267-71. PubMed ID: 6333213
[TBL] [Abstract][Full Text] [Related]
38. [Oral administration of OK-432 is an effective immunotherapy against colon cancer--a study in a murine mesenteric lymphnode metastasis model].
Nukata Y; Shiiba K; Ebine N; Ishii S; Matsuno S
Nihon Geka Gakkai Zasshi; 1995 Oct; 96(10):671-9. PubMed ID: 8538585
[TBL] [Abstract][Full Text] [Related]
39. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
Kobayashi G
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):68-76. PubMed ID: 2314383
[TBL] [Abstract][Full Text] [Related]
40. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
